Price target
13.710.000.00%
The 4 analysts offering 1 year price forecasts for XE7C have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to XE7C in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
XE7C EPS for the last quarter is −0.21 EUR despite the estimation of −0.24 EUR. In the next quarter EPS is expected to reach −0.19 EUR. Track more of CARDIFF ONCOLOGY INC financials and stay on top of what is up with the company.
In the next quarter CARDIFF ONCOLOGY INC revenue is expected to reach 76.94 K EUR. Check out CARDIFF ONCOLOGY INC revenue and earnings and make informed decisions.
According to analysts, XE7C price target is 13.71 EUR with a max estimate of 19.24 EUR and a min estimate of 9.62 EUR. Check if this forecast comes true in a year, meanwhile watch CARDIFF ONCOLOGY INC stock price chart and keep track of the current situation with XE7C news and stock market news.
We've gathered opinions of 6 analysts rating XE7C stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.